Melanotan II: What It Is and What It Does

What Melanotan II is

Melanotan II is a lab-made, ring-shaped copy of the pigment hormone alpha-MSH. It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

Melanotan II came out of the same University of Arizona melanocortin research as Melanotan I, in the early 1990s. Where Melanotan I is a linear peptide, chemists cyclized Melanotan II into a ring, which made it extremely potent and, crucially, less selective — it activates several melanocortin receptors rather than mainly the pigment one. That broad activity is exactly why it became a widely used research tool: a single molecule that can switch on pigment, appetite, and other melanocortin-controlled pathways at once. It is worth noting that it has never been approved as a medicine and is supplied here strictly as a research material.

What it does — in plain terms

Like Melanotan I, it mimics the signal that tells skin cells to make pigment — but its shape lets it hit more than one receptor, so the research on it is broader. Studies look at the melanocortin system: a family of 'switches' in the body that this hormone controls, of which pigment is just one. It's a tool for understanding how a single hormone can trigger several different responses.

How it works

Melanotan II is a broad melanocortin-receptor agonist. Its ring structure lets it activate not just the melanocortin-1 receptor that controls pigment, but also central receptors such as MC3R and MC4R in the brain. That is the key difference from Melanotan I: instead of a fairly clean pigment signal, Melanotan II presses several melanocortin buttons at once.

Because those receptors sit in different systems, the research on Melanotan II is unusually varied. In animal and cell models it has been examined for pigment production, for effects on appetite and body weight through brain melanocortin receptors, for energy expenditure (thermogenesis), and for sexual-behavior pathways — the last of which is the research lineage that later led to a separate, more receptor-selective drug, bremelanotide.

The flip side of engaging many receptors is unpredictability. A meaningful slice of the Melanotan II literature is actually about adverse effects and real-world misuse — case reports and population surveys documenting problems in people who obtained it outside any medical setting. Researchers study it as much to understand melanocortin signaling broadly as to catalog the consequences of activating that system non-selectively.

What the research shows

Melanotan II is best understood as a broad melanocortin research tool, not a finished therapy — it has never been approved, and part of its published record is a cautionary one. The provided studies span pigment biology, appetite and metabolism, and sexual behavior in animal and early human work, but they also include case reports and surveys of harm from unregulated use. Read together, they map what activating the melanocortin system non-selectively actually does. Here is what each reports.

• Life Sciences, 1996 — reported an early phase I human study of Melanotan II, finding that it stimulated melanogenesis and skin pigmentation.
• Experimental Physiology, 2021 — examined Melanotan II's effect on heat production (thermogenesis) in a mouse model, linking melanocortin signaling to energy expenditure.
• Neuropeptides, 2022 — studied how Melanotan II acts on brain melanocortin receptors to influence feeding behavior in a research model.
• Biomedicine & Pharmacotherapy, 2023 — tested Melanotan II in an animal model of diet-induced memory impairment, exploring melanocortin effects on the brain.
• Hearing Research, 2002 — examined Melanotan II in a model of cisplatin-induced hearing damage (ototoxicity).
• International Journal of Impotence Research, 2000 — reported human studies of Melanotan II as a melanocortin agonist affecting sexual response — the research line that later led to the separate drug bremelanotide.
• European Journal of Pharmacology, 2003 — examined Melanotan II's effect on nerve regeneration in a rat model.
• CEN Case Reports, 2020 — described a case of renal (kidney) infarction associated with Melanotan II use, part of the safety literature on unregulated use.
• Dermatology, 2021 — examined online-forum discussions of Melanotan II qualitatively to document how and why people use it outside medical settings, and the problems they report.
• BMJ, 2009 — surveyed real-world use of Melanotan I and II, raising public-health concerns about unregulated injectable tanning agents.
• Peptides, 2004 — found that Melanotan II influenced insulin sensitivity in a rat model, connecting melanocortin signaling to metabolism.

What Melanotan II is studied for

Skin pigmentation. The original and most direct effect: activating the melanocortin-1 receptor to drive melanin production, shown in early human and animal pigmentation studies.

Appetite, metabolism, and thermogenesis. Through central melanocortin receptors, Melanotan II has been examined in animal models for effects on feeding behavior, insulin sensitivity, and energy expenditure — a window into how the brain melanocortin system shapes metabolism.

Melanocortin signaling and sexual behavior. Human and animal work on Melanotan II's effect on sexual-response pathways helped motivate the development of a separate, more receptor-selective melanocortin drug, bremelanotide.

Safety and unregulated use. A distinct and important strand of the literature documents harms and misuse — from a kidney-infarction case report to population surveys — reflecting the risks of a non-selective, unapproved compound obtained outside medical oversight.

Storage & handling

As a lyophilized (freeze-dried) powder, Melanotan II reference material is most stable kept cold and dark — refrigerated for routine holds, or frozen for longer storage. Once reconstituted with bacteriostatic water it should be refrigerated at roughly 2-8 °C, protected from light, and kept away from repeated freeze-thaw cycles, which degrade peptides. Like other melanocortin peptides it is light-sensitive, so limiting light exposure helps preserve it. See the reconstitution reference below for the concentration math.

Reconstitution reference

Standard laboratory reconstitution volumes for Melanotan II, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.